Halozyme Therapeutics Revenue, Growth & Competitor Profile

DBA HALOZYME, INC.

Company Profile & Annual Report for Halozyme Therapeutics

Access the complete profile.

Halozyme Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	12390 El Camino Real San Diego, CA 92130

Halozyme Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Halozyme Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Halozyme Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Halozyme Therapeutics is a publicly traded company on NMS using the ticker symbol HALO. Detailed information on company financials and operating reports can be found here: NMS: HALO

Halozyme Therapeutics Annual Revenue and Growth Rate

Halozyme Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Halozyme Therapeutics's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Halozyme Therapeutics is developing and marketing. Halozyme Therapeutics doesn't have any recent trademark applications, indicating Halozyme Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VORHADIA Pharmaceutical preparations for cancer treatments	10/04/2018
DEGRYHA Pharmaceutical preparations for cancer treatment	10/04/2018
PERHAZO Pharmaceutical preparations for cancer treatment	10/04/2017

See all trademarks and details in the Full Report.

Market Share of Halozyme Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Halozyme Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Halozyme Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ILLUMINA	San Diego, CA	100
NEUROCRINE BIOSCIENCES	San Diego, CA	23
SANTARUS	San Diego, CA	16
HALOZYME THERAPEUTICS	San Diego, CA	15
MIRATI THERAPEUTICS	San Diego, CA	12
FATE THERAPEUTICS	San Diego, CA	11

Future Competition: Halozyme Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Halozyme Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)